author-photo

Kai Riecke

Bayer

3

Papers

14

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment.

2020 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (3)
The effects of weak and strong CYP3A induction by rifampicin on the pharmacokinetics of five progestins and ethinylestradiol compared to midazolam.

2020 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (5)
Effect of hepatic impairment on the pharmacokinetics of vilaprisan: an open‐label, single‐dose, parallel‐group study.

2019 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (6)